Jonas Larsson
71 – 80 of 82
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
TGF-{beta} type II receptor deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo.
(
- Contribution to journal › Article
-
Mark
Gene expression profiling demonstrates that TGF-{beta}1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-{beta} signaling.
(
- Contribution to journal › Article
- 2004
-
Mark
Defective paracrine signalling by TGF beta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia
(
- Contribution to journal › Article
-
Mark
Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction
(
- Contribution to journal › Article
-
Mark
Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice
(
- Contribution to journal › Article
- 2003
-
Mark
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
(
- Contribution to journal › Article
-
Mark
Reduced proliferative capacity of hematopoietic stem cells deficient in hoxb3 and hoxb4.
(
- Contribution to journal › Article
-
Mark
TGF-{beta} signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro.
(
- Contribution to journal › Article
- 2002
-
Mark
Transient disruption of autocrine TGF-beta signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells.
(
- Contribution to journal › Article
-
Mark
Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable.
(
- Contribution to journal › Article